{"id":"NCT00579878","sponsor":"University of Nebraska","briefTitle":"Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis","officialTitle":"Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations (Leflunomide-Hydroxychloroquine-Sulfasalazine or Methotrexate-Hydroxychloroquine-Sulfasalazine) in the Treatment of Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-03-27","primaryCompletion":"2010-03-11","completion":"2010-03-11","firstPosted":"2007-12-24","resultsPosted":"2019-05-14","lastUpdate":"2023-10-02"},"enrollment":69,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Leflunomide","otherNames":["Arava®"]},{"type":"DRUG","name":"Methotrexate-Sulfasalazine-Hydroxychloroquine","otherNames":["Trexall, Rheumatrex","Azulfidine®","Plaquenil®"]},{"type":"DRUG","name":"Leflunomide-Sulfasalazine-Hydroxychloroquine","otherNames":["Arava®","Azulfidine®","Plaquenil®"]}],"arms":[{"label":"Leflunomide alone vs combination therapy","type":"ACTIVE_COMPARATOR"},{"label":"Methotrexate-Sulfasalazine-Hydroxychloroquine","type":"ACTIVE_COMPARATOR"},{"label":"Leflunomide-Sulfasalazine-Hydroxychloroquine","type":"ACTIVE_COMPARATOR"}],"summary":"The study has been designed as a 48-week, double-blind, randomized, controlled study comparing the use of leflunomide alone to combinations of leflunomide-sulfasalazine-HCQ, and methotrexate-sulfasalazine-HCQ.","primaryOutcome":{"measure":"Measuring the Safety and Efficacy of a New DMARD, Leflunomide Alone or in Combination With Traditional DMARD's. Participants Reaching ACR 20 Response. at 48 Weeks","timeFrame":"48 weeks","effectByArm":[{"arm":"1 Leflunomide Alone vs Combination Therapy","deltaMin":8,"sd":null},{"arm":"Methotrexate-Sulfasalazine-Hydroxychloroquine","deltaMin":20,"sd":null},{"arm":"Leflunomide-Sulfasalazine-Hydroxychloroquine","deltaMin":12,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":22},"commonTop":["GI distress","Alopecia","Depression","Elevated liver enzymes","Keratitis"]}}